Abdolvahab Moradi

Abdolvahab Moradi


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 July 2014 in Journal of Biomedical Science
Verified
Journal Article
Open access
PDF file
ATAlireza Tahamtan
Alireza Tahamtan
AGAmir Ghaemi
Amir Ghaemi
Ali GorjiAli Gorji
Ali Gorji
HKHamid Reza Kalhor
Hamid Reza Kalhor
ASAzadeh Sajadian
Azadeh Sajadian
MKMishar Kelishadi
Mishar Kelishadi
Cervical cancer is the second-most-common cause of malignancies in women worldwide, and the oncogenic activity of the human papilloma virus types (HPV) E7 protein has a crucial role in anogenital tumors. In this study, we have designed a therapeutic vaccine based on chitosan nanodelivery systems to deliver HPV-16 E7 DNA vaccine, considered as a tumor specific antigen for immunotherapy of HPV-associated cervical cancer. We have developed a Nano-chitosan (NCS) as a carrier system for intramuscular administration using a recombinant DNA vaccine expressing HPV-16 E7 (NCS-DNA E7 vaccine). NCS were characterized in vitro for their gene transfection ability.

1 December 2016 in Middle East Journal of Digestive Diseases
Verified
Journal Article
Open access
PDF file
MGMahin Gholipour
Mahin Gholipour
FIFarhad Islami
Farhad Islami
GRGholamreza Roshandel
Gholamreza Roshandel
MKMasoud Khoshnia
Masoud Khoshnia
ABAbbas Badakhshan
Abbas Badakhshan
RMReza Malekzadeh
Reza Malekzadeh
Esophageal Cancer in Golestan Province, Iran: A Review of Genetic Susceptibility and Environmental Risk Factors

1 May 2020 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
SSSona Sarli
Sona Sarli
MKMohamad Reza Kalani
Mohamad Reza Kalani
AMAbdolvahab Moradi
Abdolvahab Moradi
Purpose: Paclitaxel is a generic drug produced based on Taxol which is an extract of Taxus tree, well known for its anticancer and antibacterial effects. This study was aimed at building up an agent with the antibacterial and anticancer benefits of both the silver ions and Taxol, together with less cytotoxic effects. Materials and Methods: Colloidal silver nanoparticles (AgNPs) were synthesized by reducing aqueous AgNO3 with aqueous Taxus leaf extract at nonphotomediated conditions, without any catalyst, template or surfactant. The AgNP production was confirmed by ultraviolet-visible (UV-VIS) spectroscopy, scanning electron microscopy (SEM), X-ray diffraction (XRD) and Fourier-transform infrared (FTI) spectroscopy. The MTT assay for human breast cancer cells as well as the DAPI fluorescent staining microscopy tested the biocompatibility and anticancer effects of AgNPs, silver nitrate, and Taxol. Transmission electron microscopy (TEM) and dynamic light scattering (DLS) techniques were performed to determine the shape and size of the nanoparticles. MTT assay showed the best inhibitory concentration of AgNPs on cancer cells. The antibacterial activity of the three case study materials was tested for gram-positive (Staphylococcus aureus) and gram-negative bacteria (Escherichia coli and Pseudomonas aeruginosa) using well diffusion test. Results: This work proposes more anticancer effects for AgNP made by Taxus brevifolia extract, comparing Taxol solution. IC50 was observed as 3.1 mM for Taxol while 1.5 mM for new AgNP. Moreover, Taxus showed no antibacterial effects while the new AgNP showed a dose-dependent biocompatibility along with slightly more antibacterial effects (MIC: 1.6 and 6.6mM for gram-positive and -negative bacteria, respectively) comparing with silver nitrate solution (MIC: 1.5 and 6.2 mM for gram-positive and -negative bacteria, respectively). Conclusion: The production of herbal-mediated silver nanoparticles may be an efficient substitution for the silver nitrate–based medicines with less side effects.

25 May 2013 in Virologica Sinica
Verified
Journal Article
Closed access
PDF file
MNMalihe Naderi
Malihe Naderi
ASAtefeh Saeedi
Atefeh Saeedi
AMAbdolvahab Moradi
Abdolvahab Moradi
MKMishar Kleshadi
Mishar Kleshadi
MZMohammad Reza Zolfaghari
Mohammad Reza Zolfaghari
AGAmir Ghaemi
Amir Ghaemi

25 January 2012 in Virus Genes
Verified
Journal Article
Closed access
PDF file
AMAbdolvahab Moradi
Abdolvahab Moradi
SZSareh Zhand
Sareh Zhand
AGAmir Ghaemi
Amir Ghaemi
NJNaeme Javid
Naeme Javid
ATAlijan Tabarraei
Alijan Tabarraei

1 January 2006 in Indian Journal of Medical Sciences
Verified
Journal Article
Closed access
AJAli Jabbari
Ali Jabbari
SBSima BESHARAT
Sima BESHARAT
AAAbdollah Abbasi
Abdollah Abbasi
AMAbdolvahab Moradi
Abdolvahab Moradi
KKKhodaberdi Kalavi
Khodaberdi Kalavi
Crimean-Congo hemorrhagic fever (CCHF) is a widely distributed lethal disease, worldwide. Humans are usually infected with CCHF virus through a tick bite or close contact with viral contaminated tissues or with blood of domestic animals or of infected patients. The present study reports six cases of CCHF, who were in contact with both infected tissues and blood from sheep. In some regions like Golestan province (North of Iran), clinician suspicion may have an important role in early diagnosis and treatment of the disease. Conservative therapy (intensive monitoring) and prescription of antiviral medication (Ribavirin) accompanied with corticosteroids, was useful at the early stage of CCHF.